Skip to main content

Boomerang Ventures

BOOMERANG

NEWS

Keep up with Boomerang Ventures as we launch new companies, engage new investors, close fundraising rounds, share industry insights, and achieve other significant milestones in the life of our team and portfolio companies.

Back to News Page

In the News
In The News

Mentavi Health to license MentaviDx, an online mental health evaluation, to clinics

Source: Dealroom
Dealroom features Boomerang Ventures portfolio company Mentavi Health and its upcoming launch of MentaviDx, a licensable online mental health evaluation tool for practices and organizations. MentaviDx will allow organizations to offer branded assessments within their own workflows while keeping diagnosis and clinical responsibility with their licensed clinicians.

Read More »
In the News
In The News

Mentavi Health launches EverHealth Scribe AI tool to streamline clinical documentation

Dealroom features Boomerang Ventures portfolio company Mentavi Health and the launch of EverHealth Scribe, an ambient AI documentation tool designed to reduce administrative burden for mental health clinicians. Integrated with DrChrono, the technology transcribes patient visits, generates structured draft notes, and supports more consistent documentation while keeping clinicians in full control of final records and clinical decisions.

Read More »
In the News
In The News

Mentavi Health Introduces EverHealth Scribe to Support Clinical Documentation

AP News highlights Boomerang Ventures portfolio company Mentavi Health and its launch of EverHealth Scribe, an ambient AI documentation tool integrated with the DrChrono EHR platform. The technology is designed to help clinicians streamline note generation, support documentation consistency, and spend more time focused on patient care while keeping licensed providers in control of all clinical decisions.

Read More »
In the News
In The News

Mentavi Health to Present Adult ADHD Validation Data at National Psychopharmacology Update 2026

Source: EIN Presswire
Mentavi Health will present peer-reviewed validation findings at the 31st Annual National Psychopharmacology Update, highlighting its clinically studied online adult ADHD diagnostic evaluation. The Journal of Clinical Psychiatry–published study demonstrates strong agreement with traditional clinical interviews and supports responsible expansion of digital mental health access.

Read More »
In the News
In The News

Mentavi Health Unveils AI-backed Mental Health Platform Mentavi Concierge

Source: Digital Health News
Mentavi Health has launched Mentavi Concierge, an AI-powered mental health platform designed to elevate standards of safety, transparency, and clinical oversight in digital care. The system combines advanced conversational AI with licensed clinicians, embedded safety protocols, mood tracking, and human-in-the-loop review to ensure ethical, personalized, and HIPAA-compliant support. CEO Keith Brophy emphasizes that the technology is “patient-lifting, not job-replacing,” reinforcing Mentavi’s commitment to responsible innovation in mental healthcare.

Read More »
In the News
In The News

Asynchronous ADHD Assessment: New Tools for Better Evaluation

Source: Psychiatric Times
Telepsychiatry is evolving with tools like the Mentavi Diagnostic Evaluation—an asynchronous, clinically validated ADHD assessment for adults. This innovative platform improves diagnostic accuracy, reduces wait times, and enhances patient engagement while helping clinicians make more informed treatment decisions.

Read More »

Back to News Page

Boomerang Ventures
Loading...